Artimplant in bankruptcy
The District Court of Gothenburg today decided to grant the petition for bankruptcy of Artimplant AB (publ). The Court appointed Lawyer Mr. Rickard Ström, Advokatfirman Lindahl KB, phone: +46 (0)31 799 10 00 as the trustee.
Västra Frölunda, August 1, 2013
The Board of Directors
For additional information, please contact:
Håkan Johansson, Chairman of the board, phone +46 (0)705 14 21 57
Kjell Thörnbring, CEO, phone +46 (0)703 11 90 25,
Artimplant is a biomaterials company focused on solutions to problems in orthopedic. We restore health through the development, production and marketing of degradable implants that regenerate body functions and improve quality of life. Our products, made from Artelon®, meet unmet clinical needs and are marketed in a growing number of therapy areas. Artimplant produces implants for treatment of osteoarthritis in hands and feet, for shoulder and other soft tissue injuries.
Artimplant is a public company listed on the OMX Nordic Exchange Stockholm in the Small Cap segment and in the healthcare sector.
This press release contains forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of risks and uncertainties impacting the Company's business including increased competition; the ability of the Company to expand its operations and to attract and retain qualified professionals; technological obsolescence; general economic conditions; and other risks detailed from time to time in the Company's filings.
This is information which Artimplant shall make public pursuant to the Swedish Financial Instruments Act and the Swedish Securities Exchange and Clearing Operations Act and/or stock market agreements. Information was made available for publication on August 1, 2013 at 1:30 PM (CET).